BMSSC
BIO icon

B. Metzler seel. Sohn & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Hold
1,581
– – ﹤0.01% 665
2026
Q1 		$441K Hold
1,581
– – ﹤0.01% 652
2025
Q4 		$479K Hold
1,581
– – ﹤0.01% 648
2025
Q3 		$443K Hold
1,581
– – ﹤0.01% 663
2025
Q2 		$382K Buy
1,581
+319
+25% +$75.4K ﹤0.01% 672
2025
Q1 		$307K Hold
1,262
– – ﹤0.01% 691
2024
Q4 		$415K Hold
1,262
– – ﹤0.01% 668
2024
Q3 		$422K Hold
1,262
– – ﹤0.01% 664
2024
Q2 		$345K Buy
1,262
+180
+17% +$52.4K ﹤0.01% 677
2024
Q1 		$374K Hold
1,082
– – ﹤0.01% 657
2023
Q4 		$349K Sell
1,082
-9
-0.8% -$2.82K ﹤0.01% 651
2023
Q3 		$391K Hold
1,091
– – 0.01% 611
2023
Q2 		$414K Hold
1,091
– – 0.01% 603
2023
Q1 		$523K Hold
1,091
– – 0.01% 550
2022
Q4 		$459K Buy
1,091
+55
+5% +$22.2K 0.01% 571
2022
Q3 		$432K Buy
1,036
+229
+28% +$114K 0.01% 564
2022
Q2 		$399K Hold
807
– – 0.01% 591
2022
Q1 		$455K Hold
807
– – 0.01% 617
2021
Q4 		$612K Sell
807
-511
-39% -$382K 0.01% 517
2021
Q3 		$983K Buy
1,318
+580
+79% +$434K 0.01% 441
2021
Q2 		$475K Sell
738
-81
-10% -$49.3K 0.01% 558
2021
Q1 		$468K Buy
819
+229
+39% +$136K 0.01% 560
2020
Q4 		$339K Buy
+590
New +$336K 0.01% 584

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

B. Metzler seel. Sohn & Co's BIO Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 1,581 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #665.

B. Metzler seel. Sohn & Co first reported a position in BIO in Q4 2020 and has held it in 23 quarters since. The position peaked at $983K in Q3 2021. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 1,581 shares of Bio-Rad Laboratories Class A worth $464K as of Q2 2026.
  • B. Metzler seel. Sohn & Co left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #665 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and has held it in 23 quarters since.
  • B. Metzler seel. Sohn & Co's Bio-Rad Laboratories Class A position peaked at $983K in Q3 2021.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.